Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients

NCT06395285 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

ROSAH

Interventions

DRUG: DF-003

Sponsor

Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)